Politics, Regulators, And Clinical Research

Tuesday, 08 December 2009

A panel of experts will discuss the changing regulatory landscape, what the implications are for the industry in the short to medium term and what could be considered in developing strategies to increase the safety profile of products. A recent report developed by IMS and commissioned by ICON, entitled “Safety First - The Impact of New Regulations on Clinical Research”, will also be discussed. Register Today!